Results of a new study recently published suggest an association between aspirin use and a decreased risk of developing Type 2 diabetes...
Advertisement
Dr. Yasuaki Hayashino, of the University Graduate School of Medicine, Kyoto, Japan, stated that, "Analytic studies on aspirin or non-aspirin NSAIDs and the risk of diabetes in free-living human populations are limited."
To investigate, the researchers analyzed data from the Physicians Health Study, which included 22,071 apparently healthy male physicians, and has accumulated 22 years of follow-up data.
The participants self-reported their history of diabetes, aspirin use, and various lifestyle factors at baseline and in yearly follow-up questionnaires.
A total of 1,719 cases of diabetes were reported during follow-up. Subjects who self-selected any aspirin had a multivariable-adjusted hazard ratio of developing diabetes of 0.86, compared to those that did not take aspirin.
Non-aspirin NSAIDs were not associated with a decreased risk of developing diabetes.
"Decreased risk of Type 2 diabetes may be added to the list of clinical benefits of aspirin," Dr. Hayashino and colleagues conclude. "Future studies are warranted to further investigate this association."
DISCLAIMER: The content of this Website is independent of the views of our advertisers and sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.
Copyright @ 1999-2012 Diabetes In Control, Inc.. All rights reserved.
Entries (RSS News)
